Compugen (CGEN) Gains from Investment Securities (2017 - 2021)
Compugen's (CGEN) quarterly Gains from Investment Securities came in at $1.1 million in Q4 2021, down 80.99% year-on-year from $6.0 million in Q4 2020, and down 80.99% quarter-over-quarter from $6.0 million in Q4 2020.
Compugen (CGEN) Gains from Investment Securities (2017 - 2021) Analysis & Trends
Compugen has disclosed Gains from Investment Securities across 5 years of filings, most recently posting $1.1 million for Q4 2021.
- Gains from Investment Securities for Q4 2021 came in at $1.1 million, down 80.99% year-over-year; the trailing twelve-month figure through Dec 2021 was $1.1 million (down 80.99% YoY), and the FY2025 annual result was $1000.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $1.1 million for Q4 2021 at Compugen, down from $6.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.1 million in Q4 2019 to a low of $768000.0 in Q4 2018.
- The 5-year median for Gains from Investment Securities is $1.1 million (2021), against an average of $3.4 million.
- Across the five-year window, Gains from Investment Securities jumped 954.99% in 2019 and sank 80.99% in 2021, its largest moves.
- Compugen's Gains from Investment Securities stood at $793000.0 in 2017, then dropped by 3.15% to $768000.0 in 2018, then surged by 954.99% to $8.1 million in 2019, then slipped by 26.44% to $6.0 million in 2020, then tumbled by 80.99% to $1.1 million in 2021.
- The last three Gains from Investment Securities figures came in at $1.1 million (Q4 2021), $6.0 million (Q4 2020), and $8.1 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 5.96 Mn |
| Dec 31, 2020 | 5.96 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2018 | 768,000.00 |
| Dec 31, 2018 | 768,000.00 |
| Dec 31, 2017 | 793,000.00 |
| Dec 31, 2017 | 793,000.00 |